VISUDYNE Trademark

Trademark Overview

On Tuesday, June 30, 1998, a trademark application was filed for VISUDYNE with the United States Patent and Trademark Office. The USPTO has given the VISUDYNE trademark a serial number of 75507102. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, March 4, 2022. This trademark is owned by Novartis AG. The VISUDYNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in ophthalmology and treatment of diseases of the eye
visudyne

General Information

Serial Number75507102
Word MarkVISUDYNE
Filing DateTuesday, June 30, 1998
Status800 - REGISTERED AND RENEWED
Status DateFriday, March 4, 2022
Registration Number2498651
Registration DateTuesday, October 16, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 1999

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in ophthalmology and treatment of diseases of the eye

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 5, 1998
Primary Code005
First Use Anywhere DateWednesday, April 12, 2000
First Use In Commerce DateWednesday, April 12, 2000

Trademark Owner History

Party NameCHEPLAPHARM ARZNEIMITTEL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressGREIFSWALD 17489
DE
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, March 4, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, March 4, 2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, March 4, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, March 4, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 14, 2021TEAS SECTION 8 & 9 RECEIVED
Friday, October 16, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 19, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 17, 2011REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, October 17, 2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 13, 2011TEAS SECTION 8 & 9 RECEIVED
Saturday, June 20, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 24, 2007CASE FILE IN TICRS
Wednesday, December 27, 2006REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 19, 2006ASSIGNED TO PARALEGAL
Wednesday, October 18, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, October 18, 2006TEAS SECTION 8 & 15 RECEIVED
Sunday, December 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 6, 2004PAPER RECEIVED
Tuesday, October 16, 2001REGISTERED-PRINCIPAL REGISTER
Monday, March 26, 2001ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 16, 2001STATEMENT OF USE PROCESSING COMPLETE
Friday, March 9, 2001EXTENSION 3 GRANTED
Monday, January 29, 2001EXTENSION 3 FILED
Monday, January 29, 2001USE AMENDMENT FILED
Wednesday, August 16, 2000EXTENSION 2 GRANTED
Thursday, June 29, 2000EXTENSION 2 FILED
Friday, April 7, 2000EXTENSION 1 GRANTED
Wednesday, February 2, 2000EXTENSION 1 FILED
Tuesday, August 3, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 11, 1999PUBLISHED FOR OPPOSITION
Friday, April 9, 1999NOTICE OF PUBLICATION
Thursday, February 25, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 25, 1999ASSIGNED TO EXAMINER

Related Keywords

visudyne diseases treatment ophthalmology preparations pharmaceutical